Stock Price

FIRST TRACKS BIOTHERAPEUTICS

First Tracks Biotherapeutics (TRAX) Rises 5.28% – Strong Upswing, 200‑Day SMA Support, & Growth Outlook

First Tracks Biotherapeutics (TRAX) Rises 5.28% – Strong Upswing, 200‑Day SMA Support, & Growth Outlook

First Tracks Biotherapeutics (TRAX) sees a 5.28% jump, outpacing peers and riding a bullish trend with strong fundamentals and a promising pipeline.

21/10/2026, 07:06

2 minutes to read